UAE: Burjeel Holdings reports record Q3’25 revenue

About this update from Burjeel Holdings Plc

Staff WriterBurjeel Holdings PLC (Burjeel or the Group) delivered record high revenue of AED1,422 million in Q3’25, an increase of 7.9%, underscoring the strength of its network, market positioning, and operational resilience. Top-line growth reflected robust patient footfall and an enhanced case mix, with strong contributions from high-value specialties.According to financial results, revenue in 9M’25 rose 10.6% to AED 4,099 million, with total patient visits reaching 5.1 million, up 7.3%. This reflects deeper community reach and expanding market share, as the Group’s patient volumes continue to outpace regional population growth.EBITDA increased 17.1% to AED320 million in Q3’25, with the margin expanding to 22.5% from 20.7% in Q3’24. The improvement was fully operational, supported by a higher share of complex and specialized medical services, enabled by disciplined cost management and stronger operating leverage across ramped-up and maturing assets. As a result, EBITDA rose 15.3% to AED807 million in 9M’25, with the EBITDA margin improving to 19.7% from 18.9% in 9M’24.Net profit reached AED175 million in Q3’25, up 27.5%, with the net margin rising to 12.3% from 10.4% in Q3’24. The increase reflected operating leverage and slower growth in non-operating costs relative to revenue. For 9M’25, net profit rose 18.2% to AED362 million, with the net margin strengthening to 8.8%, showcasing sustained earnings momentum.The Hospitals segment representing 88% of total Group revenue, grew 4.6% to AED 1,247 million in Q3’25 and 8.3% to AED 3,618 million in 9M’25, driven by rising patient footfall and a stronger case mix. Top contributors included Burjeel Medical City, Burjeel Specialty Hospital Sharjah, and Medeor Hospitals in Abu Dhabi and Dubai, reflecting solid operational execution and sustained demand for complex care.Hospitals EBITDA increased 20.1% in Q3’25 and 14.0% in 9M’25, with the EBITDA margin expanding to 25.8% in Q3’25 and 23.7% in 9M’25, supported by efficiency gains across inventory, workforce, and overhead costs.Burjeel Medical City (BMC), the Group’s regional hub for complex and tertiary services, delivered revenue growth of 10.9% to AED 975 million in 9M’25, with Q3’25 revenue up 7.1%. BMC’s performance reflected a higher outpatient mix, rising oncology volumes, and the continued ramp-up of specialty units, driving a 19.4% increase in patient vo...

View stock analysis, news, and events for Burjeel Holdings Plc